Photoresponsive DNA-cross-linked hydrogels for controllable release and cancer therapy

We have developed a photoresponsive DNA-cross-linked hydrogel that can be photoregulated by two wavelengths with a reversible sol-gel conversion. This photoinduced conversion can be further utilized for precisely controllable encapsulation and release of multiple loads. Specifically, photosensitive...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Langmuir : the ACS journal of surfaces and colloids. - 1992. - 27(2011), 1 vom: 04. Jan., Seite 399-408
1. Verfasser: Kang, Huaizhi (VerfasserIn)
Weitere Verfasser: Liu, Haipeng, Zhang, Xiaoling, Yan, Jilin, Zhu, Zhi, Peng, Lu, Yang, Huanghao, Kim, Youngmi, Tan, Weihong
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2011
Zugriff auf das übergeordnete Werk:Langmuir : the ACS journal of surfaces and colloids
Schlagworte:Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Azo Compounds Cross-Linking Reagents DNA, Complementary Delayed-Action Preparations Drug Carriers Hydrogels Gold mehr... 7440-57-5 Doxorubicin 80168379AG DNA 9007-49-2 Horseradish Peroxidase EC 1.11.1.- Fluorescein TPY09G7XIR
Beschreibung
Zusammenfassung:We have developed a photoresponsive DNA-cross-linked hydrogel that can be photoregulated by two wavelengths with a reversible sol-gel conversion. This photoinduced conversion can be further utilized for precisely controllable encapsulation and release of multiple loads. Specifically, photosensitive azobenzene moieties are incorporated into DNA strands as cross-linkers, such that their hybridization to complementary DNAs (cDNAs) responds differently to different wavelengths of light. On the basis of the rheology variation of hydrogels, it is possible to utilize this material for storing and releasing molecules and nanoparticles. To prove the concept, three different materials--fluorescein, horseradish peroxidase, and gold nanoparticles--were encapsulated inside the gel at 450 nm and then released by photons at 350 nm. Further experiments were carried out to deliver the chemotherapy drug doxorubicin in a similar manner in vitro. Our results show a net release rate of 65% within 10 min, and the released drug maintained its therapeutic effect. This hydrogel system provides a promising platform for drug delivery in targeted therapy and in biotechnological applications
Beschreibung:Date Completed 12.04.2011
Date Revised 20.10.2021
published: Print-Electronic
Citation Status MEDLINE
ISSN:1520-5827
DOI:10.1021/la1037553